1. Home
  2. DCTH vs JACK Comparison

DCTH vs JACK Comparison

Compare DCTH & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • JACK
  • Stock Information
  • Founded
  • DCTH 1988
  • JACK 1951
  • Country
  • DCTH United States
  • JACK United States
  • Employees
  • DCTH 76
  • JACK N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • JACK Restaurants
  • Sector
  • DCTH Health Care
  • JACK Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • JACK Nasdaq
  • Market Cap
  • DCTH 426.3M
  • JACK 360.4M
  • IPO Year
  • DCTH N/A
  • JACK 1987
  • Fundamental
  • Price
  • DCTH $11.52
  • JACK $22.75
  • Analyst Decision
  • DCTH Strong Buy
  • JACK Hold
  • Analyst Count
  • DCTH 4
  • JACK 17
  • Target Price
  • DCTH $24.00
  • JACK $38.88
  • AVG Volume (30 Days)
  • DCTH 850.4K
  • JACK 927.1K
  • Earning Date
  • DCTH 08-04-2025
  • JACK 08-06-2025
  • Dividend Yield
  • DCTH N/A
  • JACK 7.79%
  • EPS Growth
  • DCTH N/A
  • JACK N/A
  • EPS
  • DCTH N/A
  • JACK N/A
  • Revenue
  • DCTH $53,850,000.00
  • JACK $1,524,595,000.00
  • Revenue This Year
  • DCTH $155.42
  • JACK N/A
  • Revenue Next Year
  • DCTH $37.93
  • JACK N/A
  • P/E Ratio
  • DCTH N/A
  • JACK N/A
  • Revenue Growth
  • DCTH 1068.87
  • JACK N/A
  • 52 Week Low
  • DCTH $7.17
  • JACK $16.63
  • 52 Week High
  • DCTH $18.23
  • JACK $60.73
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • JACK 64.01
  • Support Level
  • DCTH $12.11
  • JACK $19.47
  • Resistance Level
  • DCTH $14.15
  • JACK $23.25
  • Average True Range (ATR)
  • DCTH 0.57
  • JACK 1.14
  • MACD
  • DCTH -0.16
  • JACK 0.74
  • Stochastic Oscillator
  • DCTH 9.67
  • JACK 92.41

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About JACK Jack In The Box Inc.

Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.

Share on Social Networks: